TESARO will host an investor briefing in connection with the 2016 European Society for Medical Oncology (ESMO) annual congress in Copenhagen, Denmark. This event will be held on Saturday, October 8 at the IDA Conference Centre, Congress Hall.
TESARO INVESTOR BRIEFING
SATURDAY, October 8, 2016
6:30 RECEPTION
7:00 PRESENTATION / WEBCAST AND Q&A
IDA CONFERENCE CENTRE
CONGRESS HALL (1st Floor)
KALVEBOD BRYGGE 31-33
1780 KØBENHAVN V
COPENHAGEN, DENMARK
A LIVE & ARCHIVED WEBCAST WILL BE AVAILABLE AT WWW.TESAROBIO.COM
During the event, Dr. Mansoor Raza Mirza, Medical Director of the Nordic Society of Gynecologic Oncology (NSGO) and principal investigator on the NOVA trial, will review the niraparib NOVA data and will be available along with TESARO management to answer questions from investors and analysts. This meeting will be webcast live and archived at www.tesarobio.com. This event is for institutional investors and sell side analysts only. All interested parties are invited to listen to the webcast.
Please RSVP to jdavis@tesarobio.com. We hope to see you in Copenhagen!
